BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32747898)

  • 21. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.
    O'Connell FP; Wang HH; Odze RD
    Arch Pathol Lab Med; 2005 Mar; 129(3):338-47. PubMed ID: 15737028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.
    Buc E; Vartanian MD; Darcha C; Déchelotte P; Pezet D
    Eur J Cancer; 2005 Jul; 41(11):1618-27. PubMed ID: 15919201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer.
    Ma YL; Peng JY; Zhang P; Liu WJ; Huang L; Qin HL
    Med Oncol; 2010 Jun; 27(2):304-9. PubMed ID: 19340613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer-Who Are These Patients?
    Bonadio RC; Freitas GF; Batista DN; Moreira OAN; Dias CAR; Castria TB; Sabbaga J; Hoff PM
    Clin Colorectal Cancer; 2021 Sep; 20(3):e195-e200. PubMed ID: 33966961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjunctival invasive poorly differentiated squamous cell carcinoma in a 91-year-old female patient.
    Todireasa AI; Costan VV; Popescu MR; Ciocoiu M
    Rom J Morphol Embryol; 2018; 59(1):375-380. PubMed ID: 29940652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
    Gurzu S; Jung I
    Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.
    Mongan JP; Fadul CE; Cole BF; Zaki BI; Suriawinata AA; Ripple GH; Tosteson TD; Pipas JM
    Clin Colorectal Cancer; 2009 Apr; 8(2):100-5. PubMed ID: 19739271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
    Tot T
    Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
    Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
    Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory juvenile compound conjunctival nevi. A clinicopathological study and literature review.
    Costea CF; Turliuc MD; Dimitriu G; Bogdănici CM; MoŢoc A; Chihaia MA; Dancă C; Cucu A; Cărăuleanu A; Dumitrescu N; Indrei L; Turliuc Ş
    Rom J Morphol Embryol; 2017; 58(3):739-747. PubMed ID: 29250649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
    Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
    Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors of colorectal cancer patients with brain metastases.
    Roussille P; Auvray M; Vansteene D; Lecomte T; Rigault E; Maillet M; Locher C; Dior M; Hautefeuille V; Artru P; Mabro M; Touchefeu Y; Marthey L; Moulin V; Louafi S; Lecaille C; Chautard R; Lièvre A; Zaanan A; Bennouna J; Berger A; Emambux S; Randrian V; Tougeron D
    Radiother Oncol; 2021 May; 158():67-73. PubMed ID: 33600872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
    Osunkoya AO; Netto GJ; Epstein JI
    Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall.
    Neri G; Arpa G; Guerini C; Grillo F; Lenti MV; Giuffrida P; Furlan D; Sessa F; Quaquarini E; Viglio A; Ubezio C; Pasini A; Ferrero S; Sampietro G; Ardizzone S; Latella G; Mescoli C; Rugge M; Zingone F; Barresi V; Ciccocioppo R; Pedrazzoli P; Corazza GR; Luinetti O; Solcia E; Paulli M; Di Sabatino A; Vanoli A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.